100Xfounder
Get Featured

Restore lives by deciphering the neural code of the brain Biotech Healthcare Hardware

About Synchron

The Problem Synchron addresses a core biotech pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.

The Solution Restore lives by deciphering the neural code of the brain Biotech Healthcare Hardware In practice, Synchron centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.

Why it's growing With the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Synchron is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Culture The team operates in a fast-paced environment focused on biotech innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.

Why it Matters

Synchron matters now because with the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Synchron is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Funding Snapshot

Total Funding: $75.00MLast Round: Series C Khosla Ventures, $75M Series C in 2022All Rounds: 1
  • Series CKhosla Ventures, $75M Series C in 2022

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

AWSReactPythonPostgreSQL

Last updated: February 23, 2026

Synchron intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Biotech with comparable market signals.

Discover Now

Newsroom and topic pages connected to Synchron.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Synchron

Common questions people ask about this profile.

What is Synchron?

Restore lives by deciphering the neural code of the brain Biotech Healthcare Hardware

Who founded Synchron?

Synchron is associated with Synchron Team on 100Xfounder.

Where is Synchron located?

Synchron is listed in New York, New York, USA.

What stage is Synchron in?

Synchron is currently mapped to Series C. Funding context: Khosla Ventures, $75M Series C in 2022

What is the latest funding round of Synchron?

Synchron's latest tracked round is Series C Khosla Ventures, $75M Series C in 2022. Total tracked rounds: 1.

Is Synchron hiring now?

Synchron hiring status: Open Roles.

What technologies does Synchron use?

Synchron is associated with AWS, React, Python, and PostgreSQL.

Is Synchron verified on 100Xfounder?

Yes. Synchron is currently marked verified on 100Xfounder as of March 3, 2026.

How can users connect with Synchron founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.